Insider Trading & Ownership - HUMPHREY RACHEL

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for HUMPHREY RACHEL

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-26
Option Award
2024-03-28
4:32 pm
N/A
N/A
Pyxis Oncology Inc.PYXSHUMPHREY RACHEL
Director
38,741$096,805
(Direct)
View
2023-03-24
Option Award
2023-03-28
4:43 pm
N/A
N/A
Pyxis Oncology Inc.PYXSHUMPHREY RACHEL
Director
58,064$058,064
(Direct)
View
2022-08-11
Option Award
2022-08-15
5:44 pm
N/A
2032-08-11
Pyxis Oncology Inc.PYXSHUMPHREY RACHEL
Director
236,220$0236,220
(Direct)
View

Ownership
2021-10-21
8:41 pm
N/A
N/A
Xilio Therapeutics Inc.XLOHUMPHREY RACHEL
Director
0$058,133
(Direct)
View
2021-02-17
Option Award
2021-02-19
6:55 pm
N/A
2031-02-16
Black Diamond Therapeutics Inc.BDTXHUMPHREY RACHEL
Chief Medical Officer
60,000$060,000
(Direct)
View
2020-09-08
Option Award
2020-09-10
4:56 pm
N/A
2030-09-08
Black Diamond Therapeutics Inc.BDTXHUMPHREY RACHEL
Chief Medical Officer
160,000$0160,000
(Direct)
View